These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 20805735)

  • 1. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and magnetic resonance imaging: The value of immunoliposomes.
    Kozlowska D; Foran P; MacMahon P; Shelly MJ; Eustace S; O'Kennedy R
    Adv Drug Deliv Rev; 2009 Dec; 61(15):1402-11. PubMed ID: 19796661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance relaxation properties of superparamagnetic particles.
    Gossuin Y; Gillis P; Hocq A; Vuong QL; Roch A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):299-310. PubMed ID: 20049798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
    Santyr GE
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs).
    Querol M; Bogdanov A
    J Magn Reson Imaging; 2006 Nov; 24(5):971-82. PubMed ID: 17024658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
    Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel imaging in cardiovascular MRI: methods and applications.
    Niendorf T; Sodickson DK
    NMR Biomed; 2006 May; 19(3):325-41. PubMed ID: 16705633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology and MRI contrast enhancement.
    Matson ML; Wilson LJ
    Future Med Chem; 2010 Mar; 2(3):491-502. PubMed ID: 21426177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D
    J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic principles of magnetic resonance contrast agents.
    Kirsch JE
    Top Magn Reson Imaging; 1991 Mar; 3(2):1-18. PubMed ID: 2025431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches.
    Sommer WH; Sourbron S; Huppertz A; Ingrisch M; Reiser MF; Zech CJ
    Abdom Imaging; 2012 Apr; 37(2):164-79. PubMed ID: 21516381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of contrast agents in body imaging.
    Bydder GM
    Top Magn Reson Imaging; 1991 Mar; 3(2):74-84. PubMed ID: 2025434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system.
    Bjørnerud A; Johansson L
    NMR Biomed; 2004 Nov; 17(7):465-77. PubMed ID: 15526351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI contrast agents: basic chemistry and safety.
    Hao D; Ai T; Goerner F; Hu X; Runge VM; Tweedle M
    J Magn Reson Imaging; 2012 Nov; 36(5):1060-71. PubMed ID: 23090917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.
    Cheng W; Ping Y; Zhang Y; Chuang KH; Liu Y
    J Healthc Eng; 2013; 4(1):23-45. PubMed ID: 23502248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging in cardiovascular diseases.
    Botnar RM; Ebersberger H; Noerenberg D; Jansen CH; Wiethoff AJ; Schuster A; Kasner M; Walter TC; Knobloch G; Hoppe P; Diederichs G; Hamm B; Makowski MR
    Rofo; 2015 Feb; 187(2):92-101. PubMed ID: 25585260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.